Chance findings in newborns genome sequencing: transformation of bioethics principles in the era of genomic technologies

Abstract

As genomic and exomic sequencing is introduced into medical practice, neonatologists, pediatricians, and geneticists are faced with the problem of how to treat the detection of accidental genetic findings in examined children, when and to what extent to report these findings to parents or other legal representatives of patients. Accidental findings are understood as genetic variants of clinical significance identified outside the target diagnostic request, including information about predisposition to endocrine, immunological, oncological, neurodegenerative and other serious diseases that manifest themselves both in childhood and adulthood.

The study analyzes the evolution of approaches to regulating information about accidental findings for medical purposes.

The concept of the “right not to know” is critically considered as a reflection of the autonomy of the patient or his representatives. Arguments against this concept include the interpersonal nature of genetic information, the potential harm of ignorance to a child’s relatives, and limited prevention options.

The concept of an “open future” proposed by philosopher Joel Feinberg, originally developed to protect the rights of a young child, is also being considered. Its influence on medical decision-making is analyzed in the context of informing patients (their parents) about random genetic findings.

As a working model of a dynamic approach to informed patient consent, a differentiated hierarchical system of medical information disclosure is proposed, allowing patients and their legal representatives to select categories of test results with the possibility of subsequent phased updating of consent, based on prioritization of random findings depending on their level of clinical significance.

The purpose of the work: to analyze the ethical problems associated with accidental findings during genome-wide or exome sequencing of newborns, and ways to overcome them; to critically analyze the bioethical concepts of “the right not to know” and “the right to an open future”; to develop solutions based on the dynamic informed consent model.

Material and methods. The research methodology included a systematic review of research on bioethics and medical genetics, and an analysis based on the principles of bioethics of proposed solutions. The recommendations of reputable international organizations such as the American College of Medical Genetics and Genomics (ACMG), the European Society of Human Genetics (ESHG) are considered.

Keywords: neonatal bioethics; genome and exome sequencing; random findings; “the right not to know”; “the right to an open future”; dynamic informed consent

Funding. The study had no sponsor support.

Conflict of interest. The authors declare no conflict of interest.

Contribution. Concept development, research – Filippova I.B.; text editing, approval of the final version of the article – Savvina O.V.

For citation: Filippova I.B., Savvina O.V. Chance findings in newborns genome sequencing: transformation of bioethics principles in the era of genomic technologies. Neonatologiya: novosti, mneniya, obuchenie [Neonatology: News, Opinions, Training]. 2025; 13 (1): 69–76. DOI: https://doi.org/10.33029/2308-2402-2025-13-1-69-76 (in Russian)

References

1. Miller D.T., Lee K., Gordon A.S., et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021; 23 (8): 1391–8. DOI: https://doi.org/10.1038/s41436-021-01171-4

2. Narravula A., Garber K.B., Askree S.H., Hegde M., Hall P.L. Variants of uncertain significance in newborn screening disorders: implications for large-scale genomic sequencing. Genet Med. 2017; 19 (1): 77–82. DOI: https://doi.org/10.1038/gim.2016.67 PMID: 27308838.

3. McCall C.M., Mosier S., Thiess M., Debeljak M., Pallavajjala A., Beierl K., et al. False positives in multiplex PCR-based next-generation sequencing have unique signatures. J Mol Diagn. 2014; 16 (5): 541–9. DOI: https://doi.org/10.1016/j.jmoldx.2014.06.001 PMID: 25017478; PMCID: PMC4188281.

4. Cuchel M., Raal F.J., Hegele R.A., Al-Rasadi K., Arca M., Averna M., et al. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance). Eur Heart J. 2023; 44 (25): 2277–91. https://doi.org/10.1093/eurheartj/ehad197 PMID: 37130090; PMCID: PMC10314327.

5. de Wert G., Dondorp W., Clarke A., Dequeker E.M.C., Cordier C., Deans Z., et al.; European Society of Human Genetics. Opportunistic genomic screening. Recommendations of the European Society of Human Genetics. Eur J Hum Genet. 2021; 29 (3): 365–77. DOI: https://doi.org/10.1038/s41431-020-00758-w PMID: 33223530; PMCID: PMC7940405.

6. Latypova M.F., Tsybin A.N., Komarov A.G., Slutsky E.A., Bodunova N.A., Danishevich A.M. Temporary Guidelines for the Implementation of NGS Testing in the Practice of Clinical Diagnostic Laboratories of the Moscow Department of Health: Methodological Recommendations. Moscow: Research Institute of Healthcare Organization and Medical Management of the Moscow City Healthcare Department; 2023: 145 p. ISBN: 978-5-907717-75-6. (in Russian)

7. National Bioethics Advisory Commission (NBCA). Research Involving Human Biological Materials: Ethical Issues and Policy Guidance: Report and Recommendations of the National Bioethics Advisory Commission. Rockville, MD: NBAC, 1999; 1.

8. Berkman B.E. Refuting the right not to know. J Health Care Law Policy. 2017; 19 (1): 1–72. PMID: 37033891; PMCID: PMC10078625.

9. UN Educational, Scientific and Cultural Organisation (UNESCO), Universal Declaration on the Human Genome and Human Rights, 11 November 1997. https://www.refworld.org/legal/resolution/unesco/1997/en/28510 (accessed 07 February 2025)

10. Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine (adopted by the Committee of Ministers on 19 November 1996). Council of Europe Convention of Biomedicine. Hum Reprod. 1997; 12 (9): 2076–80. PMID: 9363733.

11. Takala T. Genetic ignorance and reasonable paternalism. Theor Med Bioeth. 2001; 22 (5): 485–91. DOI: https://doi.org/10.1023/a:1013019120277. PMID: 11808682.

12. Andorno R. The right not to know: an autonomy-based approach. J Med Ethics. 2004; 30 (5): 435–9; discussion 439–40. DOI: https://doi.org/10.1136/jme.2002.001578. Erratum in: J Med Ethics. 2004; 30 (6): 612. PMID: 15467071; PMCID: PMC1733927.

13. Golotyuk M.A., Berezhnoy A.A., Kazantseva N.V., et al. Germline Mutations in PALB2 and CHEK2 Genes and Hereditary Cancer. Uralʹskij medicinskij žurnal [Ural Medical Journal]. 2023; 22 (3): 126–36. DOI: http://doi.org/10.52420/2071-5943-2023-22-3-126-136 (in Russian)

14. Laurie G. Recognizing the right not to know: Conceptual, professional, and legal implications. J Law Med Ethics. 2014; 42 (1): 53–63. DOI: http://doi.org/10.1111/jlme.12118

15. Harris J., Keywood K. Ignorance, information and autonomy. Theor Med Bioeth. 2001; 22 (5): 415–36. DOI: http://doi.org/10.1023/a:1013058801622 PMID: 11808677.

16. Surbone A. Social and ethical implications of BRCA testing. Ann Oncol. 2011; 22 Suppl 1: i60–6. DOI: https://doi.org/10.1093/annonc/mdq668 PMID: 21285154.

17. Wakefield C.E., Hanlon L.V., Tucker K.M., Patenaude A.F., Signorelli C., McLoone J.K., et al. The psychological impact of genetic information on children: a systematic review. Genet Med. 2016; 18 (8): 755–62. DOI: https://doi.org/10.1038/gim.2015.181 PMID: 26741411

18. Feinberg J. The child’s right to an open future. In: Feinberg J., ed. Freedom and fulfillment: philosophical essays. Princeton, NJ: Princeton University Press; 1992; 26 p.

19. Garrett J.R., Lantos J.D., Biesecker L.G., Childerhose J.E., Chung W.K., Holm I.A., et al.; Clinical Sequencing Exploratory Research (CSER) Consortium Pediatrics Working Group. Rethinking the “open future” argument against predictive genetic testing of children. Genet Med. 2019; 21 (10): 2190–8. DOI: https://doi.org/10.1038/s41436-019-0483-4 PMID: 30894702; PMCID: PMC6754817.

20. Fenwick A., Plantinga M., Dheensa S., Lucassen A. Predictive genetic testing of children for adult-onset conditions: Negotiating requests with parents. J Genet Couns. 2017; 26 (2): 244–50. DOI: https://doi.org/10.1007/s10897-016-0018-y PMID: 27680566; PMCID: PMC5382176.

21. Gillam L. Children’s bioethics and the zone of parental discretion. Monash Bioeth Rev. 2010; 29 (2): 09.1–3. PMID: 22032018.

22. Resnik D.B., Elliott, K.C., Miller, A.K. A framework for addressing ethical issues in citizen science. Environ Sci Policy. 2015; 5: 475–81.

23. Tauginienė L., Hummer P., Albert A., Cigarini A., Vohland K. Ethical Challenges and Dynamic Informed Consent. In: Vohland, K., et al. The Science of Citizen Science. Springer, Cham; 2021. DOI: https://doi.org/10.1007/978-3-030-58278-4_20

24. Cheung A.S. Moving beyond consent for citizen science in big data health and medical research. Northwestern Journal of Technology and Intellectual Property, 2018; 16 (1): 15–40.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Degtyarev Dmitriy Nikolaevich
Doctor of Medical Sciences, Professor, Deputy Director for Scientific Research of the V.I. Kulakov Obstetrics, Gynecology and Perinatology National Medical Research Center of Ministry of Healthсаre of the Russian Federation, Head of the Chair of Neonatology at the Clinical Institute of Children's Health named after N.F. Filatov, I.M. Sechenov First Moscow State Medical University, Chairman of the Ethics Committee of the Russian Society of Neonatologists, Moscow, Russian Federation

ORCID iD 0000-0001-8975-2425
geotar-digit

Journals of «GEOTAR-Media»